An NIH study documents Eylea's superiority when initial visual acuity is poor.
A poorly handled phone call likely worsened this young woman’s outcome.
Many retinal conditions can be easily confused.
Seeing spots leads to a diagnosis of idiopathic juxtafoveal retinal telangiectasis.
Can this patient’s fundus exam help you find the cause of her sudden loss of vision?
Blurry vision at near and arrhythmia and hypertension meds. Diagnosis?
Recognize when a situation calls for doctors to revert to old-model drugs.
A young patient experiences vision problems without pain. Can you identify the cause?
How would you approach this case?
Vision loss and ocular pain are clues to prompt you to ask about a history of heart disease. So, what’s the diagnosis?
After more than 20 years, is it even remotely possible to restore the visual acuity in our patient’s right eye?
With the move to 27-gauge surgery, retinal specialists continue to push the limits of instrument miniaturization in the quest for safer and more precise outcomes.
Our patient presented with evidence of a congenital retinal macrovessel. How significant is this finding, and how should he be managed?
To improve their care, optometrists have OCTs, digital cameras and automated refraction systems on their wish lists right now.
Our 58-year-old patient presented with a chief complaint of blurred vision in both eyes. What is the correct diagnosis?
Today, a multitude of diagnostic technologies can support glaucomatous, corneal and posterior segment findings detected via optical coherence tomography.
Our patient with a history of rheumatoid arthritis reported a steady loss of vision.
Was her medication to blame?
A Little More Than a Headache
Thyroid eye disease is complex and confounding. This comprehensive review connects the pathophysiology to its clinical presentation.
Eylea provides a longer duration of effect for diabetic macular edema patients than other anti-VEGF options.
Our patient presented with a fairly obvious macular pathology. But, what management protocol is most appropriate for her?
A 22-year-old white male presented with a chief complaint of decreased vision, which had progressively worsened during the past two years. How would you manage the patient?
For anti-VEGF treatment of AMD, monthly frequency and ranibizumab treatment were associated with a higher risk of geographic atrophy.
This patient returned after uncomplicated cataract surgery with an unexpected "correction" to his glaucoma. How did this happen?
A look at some of the latest product offerings in eye care.
Stem Cells to Reverse AMD Damage
This patient reported rapid vision loss in her left eye. We noted a lesion and white dots in the affected macula. What's the diagnosis?
The majority of anemias, hemoglobinopathies and hematological malignancies have retinal manifestations. Here's what you need to know when you see one.
Can Plaquenil macular toxicity continue to progress long after the patient stops taking the drug?
High blood pressure remains a major health issue worldwide, with profound-and often silent-multisystemic effects.
A specific protein, TDP-43, depletes before neurodegeneration occurs.
This patient presented with an unidentified lesion in her left eye. Is it likely to turn malignant?
In some instances, properly medicating a patient may lead to other problems.
A 54-year-old female patient has vision loss and bleeding in her left eye. What is your diagnosis?
If you suspect central serous, forget Type A personality. Instead, ask about steroids for arthritis, asthma, tennis elbow—even hemorrhoids.
The latest industry news.
This patient’s ocular history was extensive and downright perplexing. Could a cataract complication somehow affect his posterior pole?
Amyloid-beta, a key player in Alzheimer's, can be found during eye exams.
This patient presented with a lifelong history of poor visual acuity in both eyes and abnormally light skin pigmentation.